Results of the Genetic Counselor SARS-CoV-2 Impact Survey from the National Society of Genetic Counselors: Progress and penalty during the COVID-19 pandemic.


Journal

Journal of genetic counseling
ISSN: 1573-3599
Titre abrégé: J Genet Couns
Pays: United States
ID NLM: 9206865

Informations de publication

Date de publication:
08 2021
Historique:
revised: 07 06 2021
received: 19 02 2021
accepted: 04 07 2021
pubmed: 27 7 2021
medline: 29 9 2021
entrez: 26 7 2021
Statut: ppublish

Résumé

The Genetic Counselor SARS-CoV-2 Impact Survey (GCSIS) describes the impact of the pandemic on genetic counselors and genetic counseling services. With this information, the National Society of Genetic Counselors (NSGC) can better: (1) support advocacy and access efforts for genetic counseling services at both federal- and state-level; (2) promote effective billing and reimbursement for genetic counseling services provided via telemedicine; and (3) make decisions about how to best support genetic counselors. The survey was hosted on a novel data collection and analysis platform from LunaDNA and was open to all genetic counselors (n = 5,531 based on professional society membership). Survey response rate was approximately 3.8% (n = 212/5,531), with a demographic distribution broadly representative of the North American genetic counseling field. Genetic counselors remained largely employed, providing genetic counseling services throughout the pandemic, although almost one in five respondents (17%, n = 35/211) reported experiencing some degree of pandemic-related financial hardship. Nearly all respondents (90%, n = 104/115) transitioned, at least in part, to remote work settings, with about half (47%. n = 88/189) reporting restrictions in the care they were able to provide. These shifts came at a cost: existing gaps in Medicare status for genetic counselors and attendant reimbursement concerns led to uncertainty about whether genetic counselors' work will be reimbursed. Outside of work, caregiving responsibilities increased for 34% (n = 74/212) of respondents. The results of the GCSIS amplify the importance of federal- and state-level advocacy efforts for genetic counselors and their employers. They also highlight the impact of broader cultural intransigence on our majority-female profession. During the pandemic, genetic counselors continued to provide care, but without consistent financial support or expectation of reimbursement. The ability to attract and retain talented professionals to the genetic counseling field will hinge on the success of continued advocacy efforts.

Identifiants

pubmed: 34308554
doi: 10.1002/jgc4.1484
pmc: PMC8427012
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

989-998

Subventions

Organisme : NSGC

Informations de copyright

© 2021 National Society of Genetic Counselors.

Références

N Engl J Med. 2020 Jun 25;382(26):2534-2543
pubmed: 32459916
J Genet Couns. 2018 Apr;27(2):329-338
pubmed: 29362948
J Genet Couns. 2018 Sep;27(5):1175-1186
pubmed: 29502147
Nat Biotechnol. 2019 Oct;37(10):1112-1115
pubmed: 31537916
MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1049-1057
pubmed: 32790653
J Urban Health. 2021 Feb;98(1):27-40
pubmed: 33259027
J Genet Couns. 2021 Aug;30(4):989-998
pubmed: 34308554
Soc Sci Med. 2020 Dec;266:113364
pubmed: 32950924
J Genet Couns. 2021 Apr;30(2):563-573
pubmed: 33131182
J Genet Couns. 2017 Aug;26(4):852-858
pubmed: 28181058
PLoS One. 2020 Oct 30;15(10):e0241328
pubmed: 33125385

Auteurs

Vivian Pan (V)

University of Illinois Cancer Center, Chicago, Illinois, USA.

Megan Doerr (M)

Sage Bionetworks, Seattle, Washington, USA.

Christin Hoell (C)

Northwestern University, Chicago, Illinois, USA.

Lauren Ryan (L)

GRAIL, Inc, Menlo Park, California, USA.

Deanna J Erwin (DJ)

City of Hope, Duarte, California, USA.

Gillian Hooker (G)

Concert Genetics, Nashville, Tennessee, USA.

Carrie Haverty (C)

Miroculus, Inc, San Francisco, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH